Monitor the Race For a Covid-19 Vaccine
Bloomberg Markets|October - November 2020
We're offering this story for free to read so that you can stay updated on the COVID-19 outbreak
Monitor the Race For a Covid-19 Vaccine
ON AUG. 11, Russian President Vladimir Putin announced the first registration of a coronavirus vaccine, saying production was slated to begin even while drug trials continued.

That same day, President Donald Trump announced a deal for the U.S. to buy 100 million doses of Moderna Inc.’s mRNA-1273, an experimental vaccine that uses messenger RNA to instruct the body to make the virus’s spike protein and hence generate antibodies.

To monitor the development of vaccines that will help the world fight off the coronavirus pandemic, turn to Bloomberg’s news and research tools.

Bloomberg’s powerful news feed aggregates as many as 180,000 sources. You can tap into it by using natural language to build a simple search. Just type “news on coronavirus and vaccines” in the command line of a terminal screen and press . A new article matching that search criteria appears every two minutes on average. You can reduce the flow to about three stories per hour if you narrow down the sources to Bloomberg, for example.

What’s going on under the hood with natural language searches such as this? In a nutshell: news indexing. It’s the underlying infrastructure that tags every one of the more than 2 million articles and half a million tweets that come over the Bloomberg wires each day. So natural language searches such as this find articles tagged to particular news indexing codes. In this case the search pulls in stories that have been coded to two topics: coronavirus and vaccines—{NI CORONAVIR } and {NI VACCINE }.

Complex Searches Made Easy


You can read up to 3 premium stories before you subscribe to Magzter GOLD

Log in, if you are already a subscriber


Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines


October - November 2020